Lack of Association Between CYP1A1 Polymorphisms and Risk of Bladder Cancer: a Meta-analysis |
Lu, Yu
(Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
Zhang, Xiao-Lian (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Xie, Li (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Li, Tai-Jie (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) He, Yu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Peng, Qi-Liu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Deng, Yan (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Wang, Jian (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Qin, Xue (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Li, Shan (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) |
1 | Sergentanis TN, Economopoulos KP (2010). Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 122, 459-69. DOI |
2 | Wolf A, Kutz A, Plottner S, et al (2005). The effect of benzo (a)pyrene on porcine urinary bladder epithelial cells analyzed for the expression of selected genes and cellular toxicological endpoints. Toxicology, 207, 255-69. DOI |
3 | Yang XQ, Xu C, Sun Y, et al (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9. 과학기술학회마을 DOI ScienceOn |
4 | Zeegers MP, Tan FE, Dorant E, et al (2000). The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer, 89, 630-9. DOI |
5 | Pollard C, Smith SC, Theodorescu D (2010). Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med, 12, e10. DOI ScienceOn |
6 | Romkes M, White C, Johnson J, et al (1996). Expression of cytochrome P450 mRNA in human lung, head and neck tumours, and normal adjacent tissues. Proc Am Assoc Cancer Res, 37, 105. |
7 | Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev, 11, 601-6. |
8 | Shimada T (2006). Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet, 21, 257-76. DOI ScienceOn |
9 | Srivastava DS, Mandhani A, Mittal RD (2008). Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol, 82, 633-9. DOI |
10 | Thakkinstian A, McElduff P, D'Este C, et al (2005). A method for meta-analysis of molecular association studies. Stat Med, 24, 1291-306. DOI ScienceOn |
11 | Wahid M, Mahjabeen I, Baig RM, et al (2013). Expression of CYP1A1 and GSTP1 in human brain tumor tissues in Pakistan. Asian Pac J Cancer Prev, 14, 7187-91. 과학기술학회마을 DOI ScienceOn |
12 | Li X, Cui WP, Bai SF (2007). Analysis of the polymorphism of CYP1A1-MSPI gene in patients with bladder cancer. China Prac Med, 2, 3-5. DOI |
13 | Kellermann G, Shaw CRLuyten-Kellerman M (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med, 289, 934-7. DOI ScienceOn |
14 | Kogevinas M, t Mannetje A, Cordier S, et al (2003). Occupation and bladder cancer among men in Western Europe. Cancer Causes Control, 14, 907-14. DOI |
15 | Li S, Peng Q, Chen Y, et al (2013). DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis. PLoS One, 8, e73448. DOI |
16 | Lu Y, Peng Q, Zeng Z, et al (2013). CYP2D6 phenotypes and Parkinson's disease risk: A meta-analysis. J Neurol Sci, 336, 161-8. |
17 | Ozturk T, Kahraman OT, Toptas B, et al (2011). The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. In Vivo, 25, 663-8. |
18 | Manuguerra M, Matullo G, Veglia F, et al (2007). Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis, 28, 414-22. |
19 | Mooney LA, Bell DA, Santella RM, et al (1997). Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18, 503-9. DOI ScienceOn |
20 | Murray GI, Taylor VE, McKay JA, et al (1995). Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder. Int J Exp Pathol, 76, 271-6. |
21 | Peng Q, Mo C, Tang W, et al (2013). DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis. Tumour Biol, 35, 1933-44. |
22 | Hayashi S, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem, 110, 407-11. DOI |
23 | Giri SK, Yadav A, Kumar A, et al (2012). CYP1A1 gene polymorphisms: modulator of genetic damage in coal-tar workers. Asian Pac J Cancer Prev, 13, 3409-16. 과학기술학회마을 DOI ScienceOn |
24 | Grando JP, Kuasne H, Losi-Guembarovski R, et al (2009). Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med, 9, 21-8. DOI ScienceOn |
25 | Guengerich FP, Shimada T (1998). Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res, 400, 201-13. DOI ScienceOn |
26 | Jiang X, Castelao JE, Yuan JM, et al (2012). Cigarette smoking and subtypes of bladder cancer. Int J Cancer, 130, 896-901. DOI |
27 | Hiyama T, Yoshihara M, Tanaka S, et al (2008). Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol, 32, 945-73. |
28 | Ismail SI, Soubani M, Nimri JM, et al (2013). Cancer incidence in Jordan from 1996 to 2009--a comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34. 과학기술학회마을 DOI ScienceOn |
29 | Ji YN, Wang Q, Suo LJ (2012). CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS One, 7, e43397. DOI |
30 | Karbakhsh M, Dabbagh N, Shabani A, et al (2013). Age at diagnosis in bladder cancer: does opium addiction play a role? Asian Pac J Cancer Prev, 14, 4723-5. 과학기술학회마을 DOI ScienceOn |
31 | Kawajiri K, Eguchi H, Nakachi K, et al (1996). Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 56, 72-6. |
32 | Brockmoller J, Cascorbi I, Kerb R, et al (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res, 56, 3915-25. |
33 | Boffetta P, Jourenkova N, Gustavsson P (1997). Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control, 8, 444-72. DOI ScienceOn |
34 | Dai LP, Wang YP, Wu XB, et al (2009). Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis. Zhonghua Liu Xing Bing Xue Za Zhi, 30, 1198-202 (in Chinese). |
35 | Bosetti C, Pira ELa Vecchia C (2005). Bladder cancer risk in painters: a review of the epidemiological evidence, 1989-2004. Cancer Causes Control, 16, 997-1008. DOI ScienceOn |
36 | Botelho MC, Machado J, Cda Costa JM (2010). Schistosoma haematobium and bladder cancer: what lies beneath? Virulence, 1, 84-7. DOI ScienceOn |
37 | Cascorbi I, Brockmoller J, Roots I (1996). A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res, 56, 4965-9. |
38 | Dorrenhaus A, Muller TRoos PH (2007). Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch Toxicol, 81, 19-25. DOI |
39 | Fontana L, Delort L, Joumard L, et al (2009). Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort. Anticancer Res, 29, 1631-5. |
40 | Fu Jing CB-c (2013). Relationship between genetic polymorphisms of CYP1A1, NQO1, and EPHX1 and susceptibility to bladder cancer. Chin J Cancer Prev Treat, 20, 10-4. |
41 | Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28. |
42 | Vineis P, Veglia F, Garte S, et al (2007). Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol, 18, 1230-42. DOI ScienceOn |
43 | Berber U, Yilmaz I, Yilmaz O, et al (2013). CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population. Asian Pac J Cancer Prev, 14, 3925-9. 과학기술학회마을 DOI ScienceOn |
44 | Luch A (2005). Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer, 5, 113-25. DOI ScienceOn |
![]() |